Overview

A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients

Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the effectiveness and safety of FKB327 in comparison to Humira® in rheumatoid arthritis patients who have inadequate disease control on methotrexate.
Phase:
Phase 3
Details
Lead Sponsor:
Fujifilm Kyowa Kirin Biologics Co., Ltd.
Treatments:
Adalimumab